Olema Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -187 | -128 | ||
EBITDA | -49,897 | -42,174 | -47,732 | -34,745 |
EBIT | -50,084 | -42,217 | -47,864 | -34,873 |
Net Income | -46,061 | -42,217 | -43,784 | -30,389 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -38,327 | -34,527 | -29,883 | -43,979 |
Cash | 48,301 | 35,260 | 52,473 | 50,640 |
Basic Shares | 91,317 | 85,732 | 85,497 | 85,426 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -393 | -377 | -1,658 | |
EBITDA | -178,208 | -141,865 | -104,584 | -106,631 |
EBIT | -178,698 | -142,258 | -104,961 | -106,988 |
Net Income | -162,451 | -129,474 | -96,655 | -102,586 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 9,890 | |||
Free Cash Flow | -146,716 | -104,510 | -83,727 | -82,428 |
Cash | 48,301 | 139,480 | 68,539 | 23,702 |
Basic Shares | 87,006 | 58,743 | 45,247 | 39,995 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.50 |
2025-09-30 | -$0.49 |
2025-06-30 | -$0.51 |
